Peptide & Compound Guide
At a glance
| Compound | Ipamorelin |
|---|---|
| Type | Growth-hormone secretagogue research peptide |
| U.S. regulatory context | Not FDA approved |
| Evidence level | Early human and preclinical research |
| Research area | Growth-hormone secretion and endocrine research |
What is Ipamorelin?
Ipamorelin is a synthetic peptide that stimulates growth-hormone release through the ghrelin receptor pathway. It is frequently discussed in performance and anti-aging communities despite lacking FDA approval.
What does the research examine?
Early studies can help characterize pharmacology, but they do not establish broad therapeutic benefit or long-term safety.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
Claims about fat loss, muscle gain, recovery or anti-aging should be separated from what has actually been demonstrated in controlled human trials.
Related: CJC-1295 vs. Ipamorelin
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.